Analysen zu Novo Nordisk
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 31.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 27.10.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 22.10.25 | Novo Nordisk Neutral | UBS AG | |
| 22.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 20.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 17.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 13.10.25 | Novo Nordisk Neutral | UBS AG | |
| 10.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Neutral | UBS AG | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.10.25 | Novo Nordisk Neutral | UBS AG | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Novo Nordisk Neutral | UBS AG | |
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Halten | DZ BANK |
Aktuelle Aktienanalysen
| 30.01.26 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 30.01.26 | Hennes & Mauritz AB Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.26 | STMicroelectronics Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ABB Underweight | Barclays Capital | |
| 30.01.26 | Hennes & Mauritz AB Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.26 | STMicroelectronics Buy | UBS AG | |
| 30.01.26 | STRATEC Hold | Deutsche Bank AG | |
| 30.01.26 | Nemetschek Hold | Deutsche Bank AG | |
| 30.01.26 | STMicroelectronics Neutral | JP Morgan Chase & Co. | |
| 30.01.26 | easyJet Underweight | JP Morgan Chase & Co. | |
| 30.01.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 30.01.26 | ABB Kaufen | DZ BANK | |
| 30.01.26 | AIXTRON Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | secunet Security Networks Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.26 | Apple Buy | Goldman Sachs Group Inc. | |
| 30.01.26 | secunet Security Networks Buy | Warburg Research | |
| 30.01.26 | SAP Buy | Deutsche Bank AG | |
| 30.01.26 | Schaeffler Neutral | JP Morgan Chase & Co. | |
| 30.01.26 | adidas Buy | Warburg Research | |
| 30.01.26 | JENOPTIK Buy | Deutsche Bank AG | |
| 30.01.26 | adidas Neutral | Goldman Sachs Group Inc. | |
| 30.01.26 | ATOSS Software Buy | Jefferies & Company Inc. | |
| 30.01.26 | adidas Buy | Deutsche Bank AG | |
| 30.01.26 | SUSS MicroTec Buy | UBS AG | |
| 30.01.26 | adidas Buy | UBS AG | |
| 30.01.26 | Diageo Outperform | RBC Capital Markets | |
| 30.01.26 | SAP Buy | UBS AG | |
| 30.01.26 | Apple Neutral | UBS AG | |
| 30.01.26 | SAP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.26 | Deutsche Bank Outperform | RBC Capital Markets | |
| 30.01.26 | Heidelberg Materials Buy | Jefferies & Company Inc. | |
| 30.01.26 | Apple Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | SAP Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | AUTO1 Overweight | JP Morgan Chase & Co. | |
| 30.01.26 | Fraport Buy | Jefferies & Company Inc. | |
| 29.01.26 | adidas Buy | Jefferies & Company Inc. | |
| 29.01.26 | adidas Outperform | Bernstein Research | |
| 29.01.26 | Schaeffler Buy | Citigroup Corp. | |
| 29.01.26 | KION GROUP Overweight | Barclays Capital | |
| 29.01.26 | adidas Sector Perform | RBC Capital Markets | |
| 29.01.26 | Enel Overweight | Barclays Capital | |
| 29.01.26 | RWE Overweight | Barclays Capital | |
| 29.01.26 | DWS Group Outperform | RBC Capital Markets | |
| 29.01.26 | Schaeffler Buy | Jefferies & Company Inc. | |
| 29.01.26 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Nordex Buy | Jefferies & Company Inc. | |
| 29.01.26 | Tesla Buy | Deutsche Bank AG | |
| 29.01.26 | Microsoft Overweight | Barclays Capital | |
| 29.01.26 | DWS Group Equal Weight | Barclays Capital | |
| 29.01.26 | Deutsche Bank Overweight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.